¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù.
Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2022³â frontiers in immunology ¿¡ ÃâÆǵÈ
"SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation" ÀÔ´Ï´Ù.
ÀÌ ¿¬±¸¿¡¼´Â COVID-19 °¨¿° ½Ã spike, nucleocapsid SARS-CoV-2 protein ¿¡ ´ëÇÑ Ç×ü°¡ ¾î¶² ±¸¼ºÀ¸·Î Á¸ÀçÇÏ°í ¹é½Å Á¢Á¾ ÈÄ¿¡µµ ÀÌ°ÍÀÌ À¯µµµÇ´ÂÁö¿¡ ´ëÇØ È®ÀÎÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ÙÀÌ·¯½º Ç׿ø°ú Ç×üÀÇ °áÇÕÀº º¸Ã¼ÀÇ classical pathway ¸¦ È°¼ºÈÇÒ ¼ö ÀÖÀ¸¸ç, ELISA ºÐ¼®¹ýÀ» »ç¿ëÇÏ¿© Å×½ºÆ® ±×·ìÀÇ Ç×ü°¡ ÀÖ´Â »óÅ¿¡¼ S ¹× N Ç׿ø¿¡ ´ëÇÑ complement binding À» È®ÀÎÇß½À´Ï´Ù. À̸¦ ÅëÇØ complement °¡ S, N protein ¿¡ ´ëÇÑ Ç×ü¿¡ ÀÇÇØ È°¼ºÈµÇÁö¸¸ downstream effects ´Â Áúº´ÀÇ ÁßÁõµµ ¶Ç´Â ƯÁ¤ Ç׿ø¿¡ µû¶ó ´Ù¸¦ ¼ö ÀÖÀ½À» º¸¿©ÁÖ¾ú½À´Ï´Ù.
SARS-CoV-2 Ç׿ø¿¡ µû¶ó º¸Ã¼ÀÇ classical pathway activation ÀÌ ¾î¶»°Ô ´Þ¶óÁú ¼ö ÀÖ´Â Áö¿¡ ´ëÇØ °øºÎÇϱâ À§ÇØ ¼±Á¤ÇÏ¿´½À´Ï´Ù.
Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
±è¼öÁö µå¸²
³í¹®»çÀÌÆ®:
Frontiers | SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation (frontiersin.org)